Drug Immunology and Ophthalmology

Vabysmo

Payments companies reported to CMS as associated with Vabysmo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$5.4Massociated payments (2023-2025)
4,750clinicians with associated payments
5companies reporting

By year

2023 $2.8M
2024 $1.7M
2025 $824K

Payments reported as associated with Vabysmo, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Ophthalmology $2.8M
Retina Specialist $2.4M
Optometrist $55K
Uveitis and Ocular Inflammatory Disease $30K
Hospitalist $21K
Family Medicine $4,827

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Vabysmo

These are the largest totals companies reported as associated with Vabysmo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Maria Berrocal Fernandez San Juan, PR Ophthalmology $144,307.28
Rishi Singh Boston, MA Ophthalmology $135,386.56
Joseph Nezgoda West Palm Beach, FL Retina Specialist $117,673.89
Eric Nudleman San Diego, CA Ophthalmology $94,262.99
Carlos Medina Mendez Sacramento, CA Retina Specialist $87,929.97
Roger Goldberg Walnut Creek, CA Retina Specialist $87,652.11
David Eichenbaum St Petersburg, FL Ophthalmology $83,117.83
Charles Eifrig Laguna Hills, CA Retina Specialist $74,261.96
David Chin Yee Atlanta, GA Retina Specialist $73,052.82
Dilsher Dhoot Santa Barbara, CA Retina Specialist $67,971.00

Prescribed Vabysmo?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.